by Carolyn Haywood | May 1, 2016 | Briefings, UK
Prior to the 2010-2013 reforms undertaken at the former Patent County Court (PCC), now the Intellectual Property Enterprise Court (IPEC), the numbers of inquiries into damages were relatively low, partly due to the length of court actions and partly due to cost....
by Alex Bajjon | May 1, 2016 | UK
Background Positec are a company wishing to sell robotic lawnmowers in the UK. They are seeking a declaration of non-infringement and revocation through the High Court of Husqvarna’s patent (EP 1512053), which relates to a method for operating an automatic...
by David Eyre | Mar 1, 2016 | UK
In a recent article on this website we examined the case of Actavis vs Lilly and the “plausibility” test for sufficiency of disclosure used in that case. We noted that that this was a departure from the test for sufficiency that has been used previously and that this...
by David Eyre | Jan 1, 2016 | US & International
Executive Summary / Practice Points Stem cell technologies promise to be the next transformative medical technology offering therapies for conditions and diseases that are currently beyond medical science by creating replacement or supplementary tissues for a patient....
by Juliette Boynton | Jan 1, 2016 | Briefings, UK
In a second medical use patent to the “Use of tomoxetine for the manufacture of a medicament for treating attention-deficit/hyperactivity disorder”, EP(UK) 0721777, no data was provided to support the claimed invention. Actavis sought to revoke the patent on the...
Recent Comments